Clinical Trials Sponsored by Academic Myeloma Consortium
Total 34 results
-
Multiple Myeloma Research ConsortiumNot yet recruitingRefractory Multiple Myeloma | Relapse Multiple Myeloma
-
CelgeneMultiple Myeloma Research ConsortiumCompleted
-
Massachusetts General HospitalMultiple Myeloma Research ConsortiumActive, not recruitingMultiple MyelomaUnited States
-
Astex Pharmaceuticals, Inc.Multiple Myeloma Research ConsortiumCompletedMultiple MyelomaUnited States
-
Polish Myeloma ConsortiumRoche Pharma AG; Bioscience, S.A.UnknownWaldenstrom MacroglobulinemiaPoland
-
Polish Myeloma ConsortiumJanssen-Cilag Ltd.; Bioscience, S.A.Recruiting
-
University Health Network, TorontoMultiple Myeloma Research ConsortiumTerminatedMultiple Myeloma | Relapsed/RefractoryCanada
-
Emory UniversitySynta Pharmaceuticals Corp.; Multiple Myeloma Research ConsortiumCompletedMultiple MyelomaUnited States
-
PfizerAcademic GI Cancer Consortium (AGICC)Terminated
-
Massachusetts General HospitalBristol-Myers Squibb; Celgene; Multiple Myeloma Research ConsortiumActive, not recruitingMultiple MyelomaUnited States
-
University Health Network, TorontoAstellas Pharma Inc; Multiple Myeloma Research ConsortiumTerminatedMultiple MyelomaUnited States, Canada
-
Academic Thoracic Oncology Medical Investigators...AstraZenecaCompletedNon-Small Cell Lung Cancer NSCLCUnited States
-
Washington University School of MedicineMillennium Pharmaceuticals, Inc.; Multiple Myeloma Research ConsortiumActive, not recruiting
-
Wake Forest University Health SciencesIncyte Corporation; Amgen; Multiple Myeloma Research ConsortiumCompletedMultiple MyelomaUnited States
-
Onconova Therapeutics, Inc.Academic GI Cancer Consortium (AGICC)CompletedMetastatic Pancreatic AdenocarcinomaUnited States, India, Russian Federation, Hungary, Ukraine
-
Massachusetts General HospitalNovartis; Barbara Ann Karmanos Cancer Institute; Multiple Myeloma Research ConsortiumRecruitingA Study of Dabrafenib and/or Trametinib in Patients With Relapsed and/or Refractory Multiple MyelomaMultiple MyelomaUnited States
-
Barbara Ann Karmanos Cancer InstituteBristol-Myers Squibb; Janssen Pharmaceuticals; Multiple Myeloma Research ConsortiumRecruitingMultiple MyelomaUnited States
-
Icahn School of Medicine at Mount SinaiBristol-Myers Squibb; Multiple Myeloma Research ConsortiumEnrolling by invitation
-
Dana-Farber Cancer InstituteBristol-Myers Squibb; Multiple Myeloma Research Consortium; Blood Cancer Research...CompletedSmoldering Multiple MyelomaUnited States
-
Academic Thoracic Oncology Medical Investigators...University of Colorado, DenverCompletedColorectal CancerUnited States
-
Barbara Ann Karmanos Cancer InstituteBristol-Myers Squibb; National Cancer Institute (NCI); Multiple Myeloma Research...Active, not recruitingRecurrent Primary AmyloidosisUnited States
-
Emory UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH); Millennium... and other collaboratorsActive, not recruitingRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Dana-Farber Cancer InstituteJanssen Pharmaceuticals; The Leukemia and Lymphoma Society; Multiple Myeloma... and other collaboratorsActive, not recruitingSmoldering Multiple Myeloma | Monoclonal GammopathyUnited States
-
Emory UniversityNovartis; University of Chicago; University of California, San Francisco; Amgen; Onyx... and other collaboratorsCompletedMultiple MyelomaUnited States
-
Academic Thoracic Oncology Medical Investigators...Takeda Pharmaceuticals International, Inc.Active, not recruitingNon-Small Cell Lung CancerUnited States, Canada
-
Academic Thoracic Oncology Medical Investigators...University of Colorado, Denver; Celgene Corporation; Criterium, Inc.Active, not recruitingPancreatic Cancer | Pancreatic Adenocarcinoma | Pancreas Ductal AdenocarcinomaUnited States
-
Dana-Farber Cancer InstituteBristol-Myers Squibb; Celgene; The Leukemia and Lymphoma Society; Multiple Myeloma... and other collaboratorsCompletedSmoldering Multiple Myeloma | Smoldering MyelomaUnited States
-
Multiple Myeloma Research ConsortiumEli Lilly and Company; GlaxoSmithKline; AbbVie; Takeda; Genentech, Inc.; Celgene Corporation and other collaboratorsRecruitingRelapsed Refractory Multiple MyelomaUnited States
-
University of Colorado, DenverEli Lilly and Company; Merck Sharp & Dohme LLC; Criterium, Inc.; ALX Oncology Inc. and other collaboratorsActive, not recruitingMicrosatellite Stable Metastatic Colorectal CancerUnited States
-
University of RochesterNew York State Department of Health; Academic Health Center Consortium (not... and other collaboratorsCompletedTraumatic Brain InjuryUnited States
-
Criterium, Inc.University of Colorado, Denver; Georgetown University; Takeda; University of Pittsburgh and other collaboratorsTerminatedNon-Small Cell Lung CancerUnited States
-
Multiple Myeloma Research ConsortiumBristol-Myers Squibb; Memorial Sloan Kettering Cancer Center; Washington University... and other collaboratorsActive, not recruitingMultiple Myeloma | Relapsed Refractory Multiple MyelomaUnited States
-
SECRETO Study ConsortiumSahlgrenska University Hospital, Sweden; Academy of Finland; Hospital District... and other collaboratorsRecruitingIschemic Stroke | Thrombosis | Brain Infarction | Foramen Ovale, PatentItaly, Estonia, Finland, Germany, Lithuania, Netherlands, Norway, Sweden, Turkey, United Kingdom, Greece, Portugal, Spain
-
Central Clinical Hospital of the Russian Academy...Ural State Medical University; De Haar Research Task Force; De Haar Research... and other collaboratorsTerminatedCoronary Artery Disease | Alzheimer Disease | Contrast-induced Nephropathy | Coronary Atherosclerosis | Cerebrovascular Disease | Stable Chronic Angina | Chronic Coronary InsufficiencyNetherlands, Russian Federation, Estonia